FDA Clears Mylan Bladder Drug

It will sell generic Ditropan.
Publish date:

Mylan (MYL) - Get Report got Food and Drug Administration approval to sell a generic version of Alza's Ditropan extended-release tablets for treating bladder ailments.

Pittsburgh-based Mylan said it will launch its Oxybutynin Chloride tablets immediately.

"Mylan has once again differentiated itself in the industry through the successful development of this product, and based on the limited number of competitors that have filed oxybutynin applications, we expect that it will be a valuable component of our product portfolio for the 180 days of market exclusivity and beyond," the company said.